Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
Background: Streptococcus pneumoniae remains a major contributor to childhood infections and deaths globally. In Cameroon, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in July 2011, using a 3-dose Expanded programme on immunization (EPI) schedule administered to infants at 6,...
Main Authors: | John Njuma Libwea, Kirsi Gröndahl-Yli-Hannuksela, Marie Kobela, Maija Toropainen, Outi Nyholm, Paul Koki Ndombo, Sinata Koulla-Shiro, Hanna Nohynek, J. Pekka Nuorti, Jaana Vuopio, Arto A. Palmu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220304835 |
Similar Items
-
Assessing the causes of under-five mortality and proportion associated with pneumococcal diseases in Cameroon. A case-finding retrospective observational study: 2006-2012.
by: John Njuma Libwea, et al.
Published: (2019-01-01) -
Predictors to parental knowledge about childhood immunisation/EPI vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13)
by: John Njuma Libwea, et al.
Published: (2014-03-01) -
Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
by: Jukka Jokinen, et al.
Published: (2015-01-01) -
Nasopharyngeal Pneumococcal Colonization among Children after Pneumococcal Conjugate Vaccine Introduction
by: Manoochehr Karami, et al.
Published: (2017-08-01) -
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
by: John Njuma Libwea, et al.
Published: (2021-01-01)